+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Artificial Intelligence in Oncology Market Report 2025 - Product Thumbnail Image

Artificial Intelligence in Oncology Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 280 Pages
  • Global
From
Anti-CD38 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD38 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 60 Pages
  • Global
From
From
From
From
From
B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 450 Pages
  • Global
From
Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 450 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
TCR Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

TCR Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • March 2025
  • 280 Pages
  • Global
From
Refractory Metastatic Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Metastatic Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 60 Pages
  • Global
From
From
Metastatic Castration-Resistant Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 240 Pages
  • Global
From
Cervical Cancer - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 112 Pages
  • Global
From
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 180 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Follicular Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 180 Pages
  • Global
From
Ocular Melanoma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Ocular Melanoma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 71 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more